Literature DB >> 6687477

Surfactant function in respiratory distress syndrome.

M Ikegami, H Jacobs, A Jobe.   

Abstract

Airway samples from infants with respiratory distress syndrome were recovered by suction immediately after tracheal intubation for respiratory failure. The minimum surface tension of these airway samples was 27.3 +/- 3.0 dynes/cm. Surfactant with low surface tension (1.4 +/- 1.0 dynes/cm) was recovered from these samples by centrifugation; the supernatant fractions from the samples had high minimum surface tensions. The supernatant fractions contained soluble proteins that inhibited the surface tension-lowering properties of natural sheep surfactant. Similar supernatant fractions collected from infants intubated for reasons other than respiratory distress syndrome were much less inhibitory to sheep surfactant. The minimum surface tension of sequential daily airway samples from infants with respiratory distress syndrome fell progressively to 5.7 +/- 2.4 dynes/cm on the day of extubation. These results document the presence of proteins in the airways of infants with respiratory distress syndrome that inhibit the surface tension-lowering properties of surfactant.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687477     DOI: 10.1016/s0022-3476(83)80673-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

1.  Respiratory compliance in premature babies treated with artificial surfactant (ALEC).

Authors:  C J Morley; A Greenough
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

2.  Immunoglobulin profile of tracheal aspirate fluid in intubated children.

Authors:  K Forsyth; L Koh; A Lawrence; J Bradley
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

Review 3.  The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Authors:  Ronald I Clyman
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 4.  Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.

Authors:  Felicia L Bahadue; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

5.  Stable microbubble test for predicting the risk of respiratory distress syndrome: II. Prospective evaluation of the test on amniotic fluid and gastric aspirate.

Authors:  S Chida; T Fujiwara; M Konishi; H Takahashi; M Sasaki
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

Review 6.  An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.

Authors:  Paul O Nkadi; T Allen Merritt; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2009-02-04       Impact factor: 4.797

7.  In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function.

Authors:  B Lachmann; E P Eijking; K L So; D Gommers
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  The pulmonary surfactant protein C (SP-C) precursor is a type II transmembrane protein.

Authors:  A Keller; H R Eistetter; T Voss; K P Schäfer
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

9.  Hemodynamics of respiratory failure in rabbit model: effect of surfactant supplementation.

Authors:  M Barsotti; V Chundu; S Silvka; J Sephus; M Hallman
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes.

Authors:  N Evans; P Iyer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-05       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.